# A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons

> **NCT00161434** · PHASE4 · COMPLETED · sponsor: **University of Washington** · enrollment: 60 (actual)

## Conditions studied

- Herpes Simplex
- HIV Infections

## Interventions

- **DRUG:** valacyclovir
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00161434
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2008-01-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00161434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00161434, "A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00161434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*